While the COVID-19 pandemic has prompted financial catastrophe across the country, the private health insurance industry appears to be thriving. CHIR researchers Sabrina Corlette and Megan Houston consider whether the traditional use of these extra funds is the best way to spend them, and discuss opportunities that states may have to redirect money towards COVID-19 testing. Continue reading

The post As Insurers Sit on Extra Cash, is Premium Relief or MLR Rebates the Best Use of Funds? appeared first on Center on Health Insurance Reforms.

Source link